Pedro Asensi

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Spanish real-world experience with belumosudil for chronic graft-versus-host disease after two or more prior lines of therapy.

Spanish real-world experience with belumosudil for chronic graft-versus-host disease after two or more prior lines of therapy.

Journal: Transplantation and cellular therapy

Published: November 12, 2025

Spanish Real-World Experience with Belumosudil for Chronic Graft-versus-Host Disease after 2 or More Prior Lines of Therapy.

Spanish Real-World Experience with Belumosudil for Chronic Graft-versus-Host Disease after 2 or More Prior Lines of Therapy.

Journal: Transplantation and cellular therapy

Published: November 12, 2025

Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.

Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.

Journal: Transplantation and cellular therapy

Published: November 12, 2025

Patient Blood Management in Hematology: Focusing on Platelet Transfusion.

Patient Blood Management in Hematology: Focusing on Platelet Transfusion.

Journal: Journal of clinical medicine

Published: October 17, 2025

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation.

Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation.

Journal: International journal of dermatology

Published: September 16, 2025

Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Bacterial Bloodstream Infections After Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy

Published: August 08, 2025

Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole Prophylaxis.

Mold Invasive Fungal Infection in Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Posaconazole Prophylaxis.

Journal: Transplantation and cellular therapy

Published: May 26, 2025

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Journal: HemaSphere

Published: May 14, 2025

Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation.

Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: February 05, 2025

Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide.

Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy

Published: December 31, 2024

Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy.

Cytokine release syndrome: implications for transplant outcomes in haploidentical and HLA-matched HSCT using PTCy.

Journal: Bone marrow transplantation

Published: October 31, 2024

Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.

Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.

Journal: Transplantation and cellular therapy

Published: October 12, 2024

Showing 1-12 of 18

Last Updated: 09/26/2026